Isomorphic Labs has a Nobel Prize-winning platform, $600 million in fresh capital, and partnerships worth up to $3 billion with Eli Lilly and Novartis. Its first AI-designed drug was supposed to enter human clinical trials by end of 2025. It didn't. What the delay reveals about the gap between computational elegance and biological proof.

OpenClaw is the fastest-growing open-source AI agent in GitHub history: a self-hosted, messaging-native assistant that can manage your inbox, run shell commands, book flights, and extend itself with community-built skills. This is the complete story of how it was built, how it works, why it broke the internet, and why it scares cybersecurity researchers.

SoftBank wired its first $10 billion OpenAI tranche today - borrowed in full from JPMorgan, Goldman Sachs, and three Japanese banks on a 12-month unsecured loan. The deal's architecture reveals more about its risks than its headline number does.

The Maven Smart System, built by Palantir and integrated with Anthropic's Claude, compressed the US targeting cycle from hours to seconds during Operation Epic Fury. Understanding how that pipeline actually works - and what it cannot do - is essential to evaluating the accountability questions the campaign has raised.

Google Research has published TurboQuant, an algorithm that cuts the memory cost of running large AI models by at least sixfold - with no accuracy penalty and no retraining required. Memory chip stocks sold off sharply. The sell-off misread what the research actually says.